Your browser doesn't support javascript.
loading
Engineered off-the-shelf therapeutic T cells resist host immune rejection.
Mo, Feiyan; Watanabe, Norihiro; McKenna, Mary K; Hicks, M John; Srinivasan, Madhuwanti; Gomes-Silva, Diogo; Atilla, Erden; Smith, Tyler; Ataca Atilla, Pinar; Ma, Royce; Quach, David; Heslop, Helen E; Brenner, Malcolm K; Mamonkin, Maksim.
Afiliación
  • Mo F; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA.
  • Watanabe N; Graduate Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX, USA.
  • McKenna MK; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA.
  • Hicks MJ; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA.
  • Srinivasan M; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.
  • Gomes-Silva D; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA.
  • Atilla E; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA.
  • Smith T; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA.
  • Ataca Atilla P; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA.
  • Ma R; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA.
  • Quach D; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA.
  • Heslop HE; Graduate Program in Immunology, Baylor College of Medicine, Houston, TX, USA.
  • Brenner MK; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA.
  • Mamonkin M; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA.
Nat Biotechnol ; 39(1): 56-63, 2021 01.
Article en En | MEDLINE | ID: mdl-32661440

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Linfocitos T / Ingeniería Celular / Receptores Quiméricos de Antígenos / Rechazo de Injerto Límite: Animals / Humans Idioma: En Revista: Nat Biotechnol Asunto de la revista: BIOTECNOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Linfocitos T / Ingeniería Celular / Receptores Quiméricos de Antígenos / Rechazo de Injerto Límite: Animals / Humans Idioma: En Revista: Nat Biotechnol Asunto de la revista: BIOTECNOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos